speb/financial-data huggingface dataset:
Financial ratios for BANF — annual report dated 2022-12-31
Total revenue: 557420000
Net income: 193100000
Capital expenditures: 19785000
Operating cash flow: 226272000
Depreciation & amortization: 22048000
Net tangible assets: 1048798000
Owner earnings: 195363000
Return on net tangible assets (%): 18.62732385073198
Buffett classification: The Gruesome
Stock price: 82.87
P/E ratio: 14.413795394562404
Shares outstanding: 33586387
Book value: 1250836000
P/B ratio: 2.2251549289355284
Market cap (USD): 2783303890.69
Debt to equity: 0.06878919378719513
Effective tax rate (%): 18.671451194447254
COGS to revenue (%): 0
SG&A to revenue (%): 35.4822216640953
Free cash flow (dilution-adjusted): 204546000
Buyback yield (%): 0
Retained earnings: 1120292000
Receivables turnover: 1.84851600066324
Capitalized R&D asset: 0
FCF margin (%): 36.695131139894514
Rule of 40 score: 36.695131139894514
Financial ratios for BANF — annual report dated 2023-12-31
Total revenue: 609864000
Net income: 212465000
Capital expenditures: 22504000
Operating cash flow: 233045000
Depreciation & amortization: 22189000
Net tangible assets: 1234924000
Owner earnings: 212150000
Return on net tangible assets (%): 17.17919483304236
Buffett classification: The Gruesome
Stock price: 93.19
P/E ratio: 14.73144002320382
Shares outstanding: 33586387
Book value: 1433891000
P/B ratio: 2.1828126437295445
Market cap (USD): 3129915404.5299997
Debt to equity: 0.06004710260403336
Effective tax rate (%): 21.294101086135107
COGS to revenue (%): 0
SG&A to revenue (%): 35.24179161255624
Free cash flow (dilution-adjusted): 207542000
Buyback yield (%): 0.05814853645455949
Retained earnings: 1276305000
Capitalized R&D asset: 0
FCF margin (%): 34.0308658979707
Revenue growth (%): 9.408345592192601
Rule of 40 score: 43.4392114901633
Financial ratios for BANF — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 4482000
Buffett classification: The Gruesome
Stock price: 102.24
Shares outstanding: 33586387
Market cap (USD): 3433872206.8799996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BANF — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 4593000
Buffett classification: The Gruesome
Stock price: 114.26
Shares outstanding: 33586387
Market cap (USD): 3837580578.6200004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BANF — annual report dated 2024-12-31
Total revenue: 631449000
Net income: 216354000
Capital expenditures: 36652000
Operating cash flow: 261200000
Depreciation & amortization: 21681000
Net tangible assets: 1425766000
Owner earnings: 201383000
Return on net tangible assets (%): 14.124547786944
Buffett classification: The Gruesome
Stock price: 114.26
P/E ratio: 17.73750694981373
Shares outstanding: 33586387
Book value: 1621187000
P/B ratio: 2.367142457113214
Market cap (USD): 3837580578.6200004
Debt to equity: 0.0531443935832202
Effective tax rate (%): 21.40612683040239
COGS to revenue (%): 0
SG&A to revenue (%): 36.06577886733528
Free cash flow (dilution-adjusted): 221096000
Buyback yield (%): 0
Retained earnings: 1433768000
Capitalized R&D asset: 0
FCF margin (%): 35.01407081173618
Revenue growth (%): 3.5393136830506475
Rule of 40 score: 38.55338449478683
Financial ratios for BANF — quarterly report dated 2025-03-31
Total revenue: 164843000
Net income: 56112000
Capital expenditures: 11310000
Operating cash flow: 76951000
Depreciation & amortization: 5694000
Net tangible assets: 1478292000
Owner earnings: 50496000
Return on net tangible assets (%): 3.415833948908605
Buffett classification: The Gruesome
Stock price: 107.59
P/E ratio: 16.099761981973554
Shares outstanding: 33586387
Book value: 1672827000
P/B ratio: 2.1601512752544045
Market cap (USD): 3613559377.33
Debt to equity: 0.05151220060412703
Effective tax rate (%): 21.055741579673036
COGS to revenue (%): 0
SG&A to revenue (%): 35.657565077073336
Free cash flow (dilution-adjusted): 64851000
Buyback yield (%): 0
Retained earnings: 1474589000
Capitalized R&D asset: 0
FCF margin (%): 39.341069987806584
Rule of 40 score: 39.341069987806584
Financial ratios for BANF — quarterly report dated 2025-06-30
Total revenue: 169304000
Net income: 62347000
Capital expenditures: 13744000
Operating cash flow: 78123000
Depreciation & amortization: 5553000
Net tangible assets: 1534365000
Owner earnings: 54156000
Return on net tangible assets (%): 3.529538278049877
Buffett classification: The Gruesome
Stock price: 121.5
P/E ratio: 34.44859420136925
Shares outstanding: 33586387
Book value: 1728038000
P/B ratio: 2.3614909050032464
Market cap (USD): 4080746020.5
Debt to equity: 0.05326561105716425
Effective tax rate (%): 21.7905617300986
COGS to revenue (%): 0
SG&A to revenue (%): 34.93538250720597
Free cash flow (dilution-adjusted): 63460000
Buyback yield (%): 0
Retained earnings: 1521631000
Capitalized R&D asset: 0
FCF margin (%): 37.4828710485281
Revenue growth (%): 2.7062113647531287
Rule of 40 score: 40.18908241328123
Financial ratios for BANF — quarterly report dated 2025-09-30
Total revenue: 175481000
Net income: 62654000
Capital expenditures: 11709000
Operating cash flow: 75422000
Depreciation & amortization: 5587000
Net tangible assets: 1589990000
Owner earnings: 56532000
Return on net tangible assets (%): 3.5554940597110676
Buffett classification: The Gruesome
Stock price: 124.76
P/E ratio: 23.13604016343388
Shares outstanding: 33586387
Book value: 1782801000
P/B ratio: 2.3503675632445797
Market cap (USD): 4190237642.1200004
Debt to equity: 0.05489956534688953
Effective tax rate (%): 20.66201517012574
COGS to revenue (%): 0
SG&A to revenue (%): 35.07103333124384
Free cash flow (dilution-adjusted): 62656000
Buyback yield (%): 0
Retained earnings: 1567954000
Capitalized R&D asset: 0
FCF margin (%): 35.705290031399414
Revenue growth (%): 3.648466663516515
Rule of 40 score: 39.35375669491593
Financial ratios for BANF — quarterly report dated 2025-12-31
Total revenue: 181000000
Net income: 59497000
Capital expenditures: 11548000
Operating cash flow: 54782000
Depreciation & amortization: 5708000
Net tangible assets: 1650029000
Owner earnings: 53657000
Return on net tangible assets (%): 3.251882239645485
Buffett classification: The Gruesome
Stock price: 105.08
P/E ratio: 14.667958713104193
Shares outstanding: 33586387
Book value: 1854125000
P/B ratio: 1.9034625745081912
Market cap (USD): 3529257545.96
Debt to equity: 0.0529705386637902
Effective tax rate (%): 21.040198537511117
COGS to revenue (%): 0
SG&A to revenue (%): 35.018232044198896
Free cash flow (dilution-adjusted): 42274000
Buyback yield (%): 0
Retained earnings: 1611017000
Capitalized R&D asset: 0
FCF margin (%): 23.355801104972375
Revenue growth (%): 3.1450698366204883
Rule of 40 score: 26.500870941592865
Financial ratios for BANF — annual report dated 2025-12-31
Total revenue: 690628000
Net income: 240610000
Capital expenditures: 48311000
Operating cash flow: 285278000
Depreciation & amortization: 22542000
Net tangible assets: 1650029000
Owner earnings: 214841000
Return on net tangible assets (%): 13.020437822607967
Buffett classification: The Gruesome
Stock price: 105.08
P/E ratio: 14.667958713104193
Shares outstanding: 33586387
Book value: 1854125000
P/B ratio: 1.9034625745081912
Market cap (USD): 3529257545.96
Debt to equity: 0.0529705386637902
Effective tax rate (%): 21.141984412587917
COGS to revenue (%): 0
SG&A to revenue (%): 35.16393774941068
Free cash flow (dilution-adjusted): 233241000
Buyback yield (%): 0
Retained earnings: 1611017000
Capitalized R&D asset: 0
FCF margin (%): 33.77230578545903
Revenue growth (%): 9.371936609290694
Rule of 40 score: 43.144242394749725
Financial ratios for BHM.AX — annual report dated 2023-06-30
Operating income: -1767650.3311258277
Net income: -1733915.2317880795
Capital expenditures: 94649.00662251655
Depreciation & amortization: 2048.344370860927
Net tangible assets: 3460284.7682119203
Owner earnings: -1826515.8940397352
Return on net tangible assets (%): -52.78513233416843
Buffett classification: The Gruesome
Stock price: 0.052980132450331126
Shares outstanding: 316928381
Book value: 3460284.7682119203
P/B ratio: 4.852464096856861
Market cap (USD): 16790907.602649007
Debt to equity: 0
Current ratio: 14.10231192736505
Quick ratio: 14.10231192736505
Free cash flow (dilution-adjusted): -1968362.2516556291
Buyback yield (%): 1.654407687773472
Retained earnings: -2177252.317880795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -51.0839554988201
Rule of 40 score: 0
Financial ratios for BHM.AX — annual report dated 2024-06-30
Operating income: -1429299.3333333333
Net income: -1380344.6666666667
Capital expenditures: 18551.333333333332
Depreciation & amortization: 29390
Net tangible assets: 4397320.666666667
Owner earnings: -1369506
Return on net tangible assets (%): -31.144101233766435
Buffett classification: The Gruesome
Stock price: 0.05333333333333334
Shares outstanding: 316928381
Book value: 4397320.666666667
P/B ratio: 3.8438968335415153
Market cap (USD): 16902846.98666667
Debt to equity: 0.022713831346694295
Current ratio: 14.39104531214427
Quick ratio: 14.39104531214427
Interest coverage ratio: -947.3923994697303
Free cash flow (dilution-adjusted): -1146490
Buyback yield (%): 0.5964833423990513
Retained earnings: -3572112
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.00460315960421
Rule of 40 score: 0
Financial ratios for BIOFILCHEM.NS — annual report dated 2022-03-31
Total revenue: 2951641.830410128
Gross profit: 385322.431755242
Operating income: 119345.90531451932
Net income: 92100.75168139259
Capital expenditures: 9217.98760385072
Operating cash flow: -28999.07688250033
Depreciation & amortization: 57708.031122247135
Net tangible assets: 2220453.6463141236
Owner earnings: 140590.795199789
Return on net tangible assets (%): 6.331624865628916
Capex to operating income (%): 7.723756906077349
Buffett classification: The Great
Stock price: 0.7602531979427667
P/E ratio: 134.3334149484536
Shares outstanding: 16273800
Book value: 2220453.6463141236
P/B ratio: 5.571928291868842
Market cap (USD): 12372208.492680997
Debt to equity: 0.027598781306235415
Current ratio: 6.23026491838373
Quick ratio: 5.365132459191865
Effective tax rate (%): 31.185338456990834
Interest coverage ratio: 23.205128205128204
COGS to revenue (%): 86.94548817592472
SG&A to revenue (%): 0.872564481755673
Free cash flow (dilution-adjusted): -38217.064486351046
Buyback yield (%): 0
Retained earnings: -4359686.140050112
Inventory turnover: 15.048252397154345
Receivables turnover: 3.1200496257161574
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.250211748871639
FCF margin (%): -1.2947731019600308
Rule of 40 score: -1.2947731019600308
Financial ratios for BIOFILCHEM.NS — annual report dated 2023-03-31
Total revenue: 3658367.8440925702
Gross profit: 318136.41900121805
Operating income: 89963.45919610233
Net income: 68258.22168087699
Capital expenditures: 1291.1084043848966
Operating cash flow: -13617.53958587089
Depreciation & amortization: 52265.52984165652
Net tangible assets: 2107369.0621193666
Owner earnings: 119232.64311814861
Return on net tangible assets (%): 5.6578909343120545
Capex to operating income (%): 1.4351475764960737
Buffett classification: The Great
Stock price: 0.5042630937880633
P/E ratio: 120.22400428265523
Shares outstanding: 16273800
Book value: 2107369.062119367
P/B ratio: 3.89408617749906
Market cap (USD): 8206276.735688185
Debt to equity: 0.030188133976822816
Current ratio: 1.628654693818076
Quick ratio: 1.5402498998215002
Effective tax rate (%): 29.331651954602773
Interest coverage ratio: 17.627684964200476
COGS to revenue (%): 91.30387012571916
SG&A to revenue (%): 0.5077375878968676
Free cash flow (dilution-adjusted): -14908.647990255786
Buyback yield (%): 0
Retained earnings: -3970243.605359318
Inventory turnover: 22.60037910004945
Receivables turnover: 1.464938764162769
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.17755455255031
FCF margin (%): -0.40752184103984657
Revenue growth (%): 23.94348821056799
Rule of 40 score: 23.535966369528143
Financial ratios for BIOFILCHEM.NS — annual report dated 2024-03-31
Total revenue: 4800971.339489147
Gross profit: 303129.87168725266
Operating income: 50029.979613862575
Net income: 85046.16860534836
Capital expenditures: 2746.132629811728
Operating cash flow: 287048.80681136827
Depreciation & amortization: 47895.43110684735
Net tangible assets: 2182851.660870608
Owner earnings: 130195.46708238396
Return on net tangible assets (%): 5.964467005076141
Capex to operating income (%): 5.488974113135186
Buffett classification: The Great
Stock price: 0.7269673704414588
P/E ratio: 139.10704958372713
Shares outstanding: 16273800
Book value: 2182851.660870608
P/B ratio: 5.4197551785867715
Market cap (USD): 11830521.593090212
Debt to equity: 0.024111675126903553
Current ratio: 1.3464775894406562
Quick ratio: 1.2570912724149415
Effective tax rate (%): 18.03998613197735
Interest coverage ratio: 10.053012048192771
COGS to revenue (%): 95.2182199209198
SG&A to revenue (%): 0.37891560697684296
Free cash flow (dilution-adjusted): 284302.67418155656
Buyback yield (%): 0
Retained earnings: -3800743.4944237918
Inventory turnover: 14.951131505667334
Receivables turnover: 1.2121220378393598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2480628509230423
FCF margin (%): 5.92177403441463
Revenue growth (%): 31.232602736808463
Rule of 40 score: 37.15437677122309
Financial ratios for BIOFILCHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 2197384.137601529
Buffett classification: The Gruesome
Stock price: 0.9788580984233158
Shares outstanding: 16273800
Book value: 2197384.137601529
P/B ratio: 7.249411083630038
Market cap (USD): 15929740.922121357
Debt to equity: 0.02473840132633925
Current ratio: 1.4433661682740615
Quick ratio: 1.1512010374352677
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOFILCHEM.NS — quarterly report dated 2024-12-31
Total revenue: 1654645.0635272176
Gross profit: 66732.71943116913
Operating income: 24303.53188017251
Net income: 19186.38535959902
Capital expenditures: 0
Depreciation & amortization: 11504.83739363562
Owner earnings: 30691.222753234637
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.6696584683529548
P/E ratio: 142.00027490886998
Shares outstanding: 16273800
Market cap (USD): 10897887.982282316
Effective tax rate (%): 25.767148014440433
Interest coverage ratio: 21.275510204081634
COGS to revenue (%): 95.96694657348962
SG&A to revenue (%): 0.3578674481514878
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIOFILCHEM.NS — quarterly report dated 2025-03-31
Total revenue: 976268.4124386251
Gross profit: 63958.38204348842
Operating income: 2875.8475566986203
Net income: 23345.803133037174
Capital expenditures: 0
Depreciation & amortization: 9749.824643441663
Net tangible assets: 2195651.157353285
Owner earnings: 33095.62777647884
Return on net tangible assets (%): 1.507326319376411
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.48033609522698095
P/E ratio: 83.70769578968756
Shares outstanding: 16273800
Book value: 2195651.157353285
P/B ratio: 3.560170986327173
Market cap (USD): 7816893.546504843
Debt to equity: 0.02509370873620991
Current ratio: 1.3361592830879467
Quick ratio: 1.231241188531668
Effective tax rate (%): 21.315996847911737
Interest coverage ratio: 3.2800000000000002
COGS to revenue (%): 93.44868877978685
SG&A to revenue (%): 2.5002993653454673
Buyback yield (%): 0
Inventory turnover: 2.3355180463278864
Receivables turnover: 0.21795641393710033
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.12871022932395734
Revenue growth (%): -40.99831837303479
Rule of 40 score: -40.99831837303479
Financial ratios for BIOFILCHEM.NS — annual report dated 2025-03-31
Total revenue: 3904863.2218844984
Gross profit: 244505.49450549448
Operating income: 54699.55576338555
Net income: 65209.2588262801
Capital expenditures: 11702.127659574468
Operating cash flow: -224877.25040916528
Depreciation & amortization: 44376.899696048626
Net tangible assets: 2195651.157353285
Owner earnings: 97884.03086275425
Return on net tangible assets (%): 4.4580866379861135
Capex to operating income (%): 21.39346014105578
Buffett classification: The Great
Stock price: 0.48033609522698095
P/E ratio: 119.87398242524637
Shares outstanding: 16273800
Book value: 2195651.157353285
P/B ratio: 3.560170986327173
Market cap (USD): 7816893.546504843
Debt to equity: 0.02509370873620991
Current ratio: 1.3361592830879467
Quick ratio: 1.231241188531668
Effective tax rate (%): 24.22225241135715
Interest coverage ratio: 12.680216802168022
COGS to revenue (%): 93.73843639041739
SG&A to revenue (%): 1.3741609834082786
Free cash flow (dilution-adjusted): -236579.37806873975
Buyback yield (%): 0
Retained earnings: -3637573.0652326397
Inventory turnover: 9.370533309391273
Receivables turnover: 0.8717786767584497
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.448110418726815
FCF margin (%): -6.058582967588961
Revenue growth (%): -18.665141993953252
Rule of 40 score: -24.723724961542214
Financial ratios for BIOFILCHEM.NS — quarterly report dated 2025-06-30
Total revenue: 752703.0189562369
Gross profit: 51837.116779780015
Operating income: -7044.231219283876
Net income: 282120.29019424296
Capital expenditures: 0
Depreciation & amortization: 7722.911303533818
Owner earnings: 289843.2014977768
Buffett classification: The Gruesome
Stock price: 0.5519541305874094
P/E ratio: 27.66771153784019
Shares outstanding: 16273800
Market cap (USD): 8982391.130353384
Effective tax rate (%): 12.723981900452491
Interest coverage ratio: -6.473118279569893
COGS to revenue (%): 93.11320461399745
SG&A to revenue (%): 0.9094300904766347
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -22.899992526025017
Rule of 40 score: -22.899992526025017
Financial ratios for BIOFILCHEM.NS — quarterly report dated 2025-09-30
Total revenue: 1526583.9909808342
Gross profit: 41668.54565952649
Operating income: 5456.595264937993
Net income: 9425.028184892897
Capital expenditures: 0
Depreciation & amortization: 7440.811724915445
Net tangible assets: 2401837.6550169108
Owner earnings: 16865.839909808343
Return on net tangible assets (%): 0.7022056580127017
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.46944757609921084
P/E ratio: 22.86803453324279
Shares outstanding: 16273800
Book value: 2401837.6550169108
P/B ratio: 3.1807711682618067
Market cap (USD): 7639695.963923337
Debt to equity: 0.0009387776176640397
Current ratio: 1.4355524457279072
Quick ratio: 1.3323005674776596
Effective tax rate (%): 25.156669650850493
Interest coverage ratio: 484
COGS to revenue (%): 97.27047146401985
SG&A to revenue (%): 0.5701287959352476
Buyback yield (%): 0
Inventory turnover: 3.782110552763819
Receivables turnover: 0.33212656364974247
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.22370744243231006
Revenue growth (%): 102.81358683770495
Rule of 40 score: 102.81358683770495
Financial ratios for BIOFILCHEM.NS — quarterly report dated 2025-12-31
Total revenue: 95388.2143254985
Gross profit: 48045.00389885263
Operating income: 3219.3383090119196
Net income: 8822.546507742009
Capital expenditures: 0
Depreciation & amortization: 7352.122089785006
Owner earnings: 16174.668597527016
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.37395566447588285
P/E ratio: 18.79957596406843
Shares outstanding: 16273800
Market cap (USD): 6085679.692547622
Effective tax rate (%): 25.773195876288664
Interest coverage ratio: 57.800000000000004
COGS to revenue (%): 49.632138269298146
SG&A to revenue (%): 16.944995912647435
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -93.75152530820061
Rule of 40 score: -93.75152530820061
Financial ratios for BOE.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.0827067669172932
Shares outstanding: 415175320
Market cap (USD): 449513128.42105263
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOE.AX — annual report dated 2022-06-30
Operating income: -4617527.586206896
Net income: 21508271.03448276
Capital expenditures: 2082826.206896552
Depreciation & amortization: 28184.137931034482
Net tangible assets: 163149606.20689654
Owner earnings: 19453628.96551724
Return on net tangible assets (%): 11.923797683487704
Buffett classification: The Gruesome
Stock price: 1.2206896551724138
P/E ratio: 23.563038488513463
Shares outstanding: 415175320
Book value: 163149606.20689657
P/B ratio: 3.106352690574091
Market cap (USD): 506800218.20689654
Debt to equity: 0.0005976532755345528
Current ratio: 55.93759144703652
Quick ratio: 55.93759144703652
Effective tax rate (%): 0
Interest coverage ratio: -44.24380492962399
Free cash flow (dilution-adjusted): -5083941.379310345
Buyback yield (%): 0
Retained earnings: -31548399.31034483
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.7239953476148195
Rule of 40 score: 0
Financial ratios for BOE.AX — annual report dated 2023-06-30
Operating income: -4376158.940397351
Net income: 8309271.523178807
Capital expenditures: 26460264.90066225
Depreciation & amortization: 51655.629139072844
Net tangible assets: 165878145.69536424
Owner earnings: -18099337.74834437
Return on net tangible assets (%): -10.911225027547548
Buffett classification: The Gruesome
Stock price: 2.052980132450331
P/E ratio: 102.57778688132622
Shares outstanding: 415175320
Book value: 166065562.9139073
P/B ratio: 5.132591420447521
Market cap (USD): 852346683.4437085
Debt to equity: 0.00037884981197085644
Current ratio: 11.66564181398924
Quick ratio: 11.66564181398924
Effective tax rate (%): 0
Interest coverage ratio: -56.96551724137932
Free cash flow (dilution-adjusted): -28802649.006622516
Buyback yield (%): 0
Retained earnings: -21985430.46357616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.542193565264895
Rule of 40 score: 0
Financial ratios for BOE.AX — annual report dated 2024-06-30
Operating income: -9784000
Net income: 29728000
Capital expenditures: 60274000
Depreciation & amortization: 257333.33333333334
Net tangible assets: 340145333.3333333
Owner earnings: -30288666.666666668
Return on net tangible assets (%): -8.904625081827769
Buffett classification: The Gruesome
Stock price: 2.7533333333333334
P/E ratio: 38.452504296734844
Shares outstanding: 415175320
Book value: 340202666.6666666
P/B ratio: 3.360103137737506
Market cap (USD): 1143116047.7333333
Debt to equity: 0.0012698313162350287
Current ratio: 10.292266047950502
Quick ratio: 7.8962103634957455
Effective tax rate (%): 6.5744814582023885
Interest coverage ratio: -90.5925925925926
Free cash flow (dilution-adjusted): -68054666.66666667
Buyback yield (%): 0.4775251539413317
Retained earnings: 7596000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.78966326734273
Rule of 40 score: 0
Financial ratios for BOF — annual report dated 2023-12-31
Total revenue: 3184018
Gross profit: -96230
Operating income: -2741073
Net income: -3925710
Capital expenditures: 116565
Operating cash flow: -3529372
Depreciation & amortization: 223856
Net tangible assets: 2210476
Owner earnings: -3818419
Return on net tangible assets (%): -172.74193431640967
Buffett classification: The Gruesome
Stock price: 1.21
Shares outstanding: 15316030
Book value: 2210476
P/B ratio: 8.383893921490213
Market cap (USD): 18532396.3
Debt to equity: 0.16576972561565925
Current ratio: 2.154098419572503
Quick ratio: 1.7217944455925032
Interest coverage ratio: -6.297394037277925
COGS to revenue (%): 91.77350756182912
SG&A to revenue (%): 83.06620754028401
Free cash flow (dilution-adjusted): -3645937
Buyback yield (%): 0
Retained earnings: -12810541
Inventory turnover: 8.675895547868945
Receivables turnover: 4.8604728553895375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -116.84003231024658
FCF margin (%): -114.50742426707387
Revenue growth (%): 258.2003683232965
Rule of 40 score: 143.69294405622264
Financial ratios for BOF — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.6
Shares outstanding: 15316030
Market cap (USD): 24505648
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOF — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.73
Shares outstanding: 15316030
Market cap (USD): 26496731.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOF — annual report dated 2024-12-31
Total revenue: 6777079
Gross profit: 781797
Operating income: -3902441
Net income: -4751516
Capital expenditures: 2847207
Operating cash flow: -4859816
Depreciation & amortization: 205907
Net tangible assets: 2341583
Owner earnings: -7392816
Return on net tangible assets (%): -315.7187253238514
Buffett classification: The Gruesome
Stock price: 1.73
Shares outstanding: 15316030
Book value: 2341583
P/B ratio: 11.315734654718625
Market cap (USD): 26496731.9
Debt to equity: 3.448350538930288
Current ratio: 0.5578189506779899
Quick ratio: 0.33878833164889116
Interest coverage ratio: -5.046594903282373
COGS to revenue (%): 83.4093419893733
R&D to revenue (%): 0.26818338697247
SG&A to revenue (%): 68.85065084824893
Free cash flow (dilution-adjusted): -7707023
Buyback yield (%): 0
Retained earnings: -17562057
Inventory turnover: 2.9280572483793352
Receivables turnover: 15.08689612491457
Capitalized R&D asset: 18175
ROCI (R&D-adjusted, %): -95.81952194067699
FCF margin (%): -113.72189995129169
Revenue growth (%): 112.84675526331824
Rule of 40 score: -0.8751446879734459
Financial ratios for BOF — quarterly report dated 2025-03-31
Total revenue: 3232291
Gross profit: 529856
Operating income: -645171
Net income: -918382
Capital expenditures: 377841
Operating cash flow: -1937207
Depreciation & amortization: 199430
Net tangible assets: 3881039
Owner earnings: -1096793
Return on net tangible assets (%): -28.260293184376657
Buffett classification: The Gruesome
Stock price: 2.46
Shares outstanding: 15316030
Book value: 3881039
P/B ratio: 9.708079150969624
Market cap (USD): 37677433.8
Debt to equity: 2.0636692906203726
Current ratio: 0.679107381915258
Quick ratio: 0.49268403019091467
Interest coverage ratio: -2.3178658293425114
COGS to revenue (%): 81.70696883417983
R&D to revenue (%): 0.23952051346862024
SG&A to revenue (%): 36.11323980421317
Free cash flow (dilution-adjusted): -2315048
Buyback yield (%): 0
Retained earnings: -18480439
Inventory turnover: 1.6611496433349455
Receivables turnover: 2.1727759284554247
Capitalized R&D asset: 7742
ROCI (R&D-adjusted, %): -11.447829214323498
FCF margin (%): -71.62251171073396
Rule of 40 score: -71.62251171073396
Financial ratios for BOF — quarterly report dated 2025-06-30
Total revenue: 3430029
Gross profit: 606459
Operating income: -1346021
Net income: -1603156
Capital expenditures: 113491
Operating cash flow: -2005649
Depreciation & amortization: 153205
Net tangible assets: 3542610
Owner earnings: -1563442
Return on net tangible assets (%): -44.1324898873994
Buffett classification: The Gruesome
Stock price: 2.43
Shares outstanding: 15316030
Book value: 3542610
P/B ratio: 10.50580021509565
Market cap (USD): 37217952.900000006
Debt to equity: 2.050607602869071
Current ratio: 1.1458983822483548
Quick ratio: 0.8067393980733624
Interest coverage ratio: -5.10368741350219
COGS to revenue (%): 78.52058976760839
SG&A to revenue (%): 56.923133886040034
Free cash flow (dilution-adjusted): -2119140
Buyback yield (%): 0
Retained earnings: -20083595
Inventory turnover: 1.7495572967755095
Receivables turnover: 1.4728961488170769
Capitalized R&D asset: 5187.14
ROCI (R&D-adjusted, %): -15.649238910854823
Rosenberg metric: 9.894471712735728
FCF margin (%): -61.781984933655075
Revenue growth (%): 6.117580378746839
Rule of 40 score: -55.66440455490824
Financial ratios for BOF — quarterly report dated 2025-09-30
Total revenue: 3269989
Gross profit: 569550
Operating income: -1427504
Net income: -1572552
Capital expenditures: 82659
Operating cash flow: -1121161
Depreciation & amortization: 153606
Net tangible assets: 5112765
Owner earnings: -1501605
Return on net tangible assets (%): -29.369724601072022
Buffett classification: The Gruesome
Stock price: 2.05
Shares outstanding: 15316030
Book value: 5112765
P/B ratio: 6.1410726876748685
Market cap (USD): 31397861.499999996
Debt to equity: 1.3862424734952614
Current ratio: 1.6340930161015879
Quick ratio: 1.0156862252211327
Interest coverage ratio: -9.582879084879568
COGS to revenue (%): 81.05461516843023
R&D to revenue (%): 5.8371755990616485
SG&A to revenue (%): 55.23501761015098
Free cash flow (dilution-adjusted): -1203820
Buyback yield (%): 0
Retained earnings: -21656147
Inventory turnover: 1.2825898231989872
Receivables turnover: 1.7581663607339375
Capitalized R&D asset: 193429.86
ROCI (R&D-adjusted, %): -11.320039642671645
FCF margin (%): -36.8141911180741
Revenue growth (%): -4.665849763952433
Rule of 40 score: -41.48004088202653
Financial ratios for BOF — annual report dated 2025-12-31
Total revenue: 14337746
Gross profit: 2034447
Operating income: -4961955
Net income: -6124672
Capital expenditures: 747043
Operating cash flow: -6999712
Depreciation & amortization: 616581
Net tangible assets: 5571707
Owner earnings: -6255134
Return on net tangible assets (%): -112.2660254747782
Buffett classification: The Gruesome
Stock price: 3.18
Shares outstanding: 15316030
Book value: 5571707
P/B ratio: 8.741481811588443
Market cap (USD): 48704975.400000006
Debt to equity: 1.1845301628387852
Current ratio: 0.9068070983181603
Quick ratio: 0.5263599657178242
Interest coverage ratio: -6.629233823560847
COGS to revenue (%): 81.53384778890629
R&D to revenue (%): 1.883099337929407
SG&A to revenue (%): 46.91398494575088
Free cash flow (dilution-adjusted): -7746755
Buyback yield (%): 0
Retained earnings: -23686729
Inventory turnover: 4.9013537916354135
Receivables turnover: 7.144350018561289
Capitalized R&D asset: 282171.25
ROCI (R&D-adjusted, %): -56.51100771058317
Rosenberg metric: 68.92159559834938
FCF margin (%): -54.03049405394683
Revenue growth (%): 111.5623264831353
Rule of 40 score: 57.53183242918846
Financial ratios for BOF — quarterly report dated 2025-12-31
Total revenue: 4405437
Gross profit: 305923
Operating income: -1505890
Net income: -2030582
Capital expenditures: 173052
Operating cash flow: -1935695
Depreciation & amortization: 157415
Net tangible assets: 5571707
Owner earnings: -2046219
Return on net tangible assets (%): -36.72517237536001
Buffett classification: The Gruesome
Stock price: 3.18
Shares outstanding: 15316030
Book value: 5571707
P/B ratio: 8.741481811588443
Market cap (USD): 48704975.400000006
Debt to equity: 1.1845301628387852
Current ratio: 0.9068070983181603
Quick ratio: 0.5263599657178242
Interest coverage ratio: -15.881732564148535
COGS to revenue (%): 84.10863666873458
R&D to revenue (%): 1.4012003803481925
SG&A to revenue (%): 39.72554822597622
Free cash flow (dilution-adjusted): -2108747
Buyback yield (%): 0
Retained earnings: -23686729
Inventory turnover: 1.5535556683866656
Receivables turnover: 2.1951835325246094
Capitalized R&D asset: 189615.25
ROCI (R&D-adjusted, %): -18.237865240504597
Rosenberg metric: -1.3811499672560577
FCF margin (%): -47.866919899206366
Revenue growth (%): 34.7232972343332
Rule of 40 score: -13.143622664873163
Financial ratios for CLAR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.45
Shares outstanding: 38441486
Market cap (USD): 978335818.6999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLAR — annual report dated 2022-12-31
Total revenue: 315251000
Gross profit: 109953000
Operating income: -10861000
Net income: -69780000
Capital expenditures: 7751000
Operating cash flow: 14610000
Depreciation & amortization: 22952000
Net tangible assets: 149133000
Owner earnings: -54579000
Return on net tangible assets (%): -36.59753374504637
Buffett classification: The Gruesome
Stock price: 7.25
Shares outstanding: 38441486
Book value: 292108000
P/B ratio: 0.9541018167937886
Market cap (USD): 278700773.5
Debt to equity: 0.5294172018568475
Current ratio: 3.69407848904714
Quick ratio: 2.0282839229042495
Interest coverage ratio: -1.3756808106396454
COGS to revenue (%): 65.1220773288586
SG&A to revenue (%): 38.323113963159514
Free cash flow (dilution-adjusted): -5001000
Buyback yield (%): 2.966263744510203
Retained earnings: -336843000
Inventory turnover: 1.907938514154012
Receivables turnover: 6.161096779237023
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.3946643148495204
FCF margin (%): -1.5863549996669322
Rule of 40 score: -1.5863549996669322
Financial ratios for CLAR — annual report dated 2023-12-31
Total revenue: 286020000
Gross profit: 97511000
Operating income: -18856000
Net income: -10146000
Capital expenditures: 5518000
Operating cash flow: 31924000
Depreciation & amortization: 20350000
Net tangible assets: 152807000
Owner earnings: 4686000
Buffett classification: The Gruesome
Stock price: 6.46
Shares outstanding: 38441486
Book value: 292120000
P/B ratio: 0.8501026960153362
Market cap (USD): 248331999.56
Debt to equity: 0.46555867451732164
Current ratio: 1.753571553933097
Quick ratio: 1.2188095990265249
COGS to revenue (%): 65.90762883714426
SG&A to revenue (%): 40.68491713866163
Free cash flow (dilution-adjusted): 20665000
Buyback yield (%): 0.08939645329371342
Retained earnings: -350739000
Inventory turnover: 2.0622586397400693
Receivables turnover: 5.213349616317008
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.812505394508082
FCF margin (%): 7.225019229424516
Revenue growth (%): -9.272294140224774
Rule of 40 score: -2.047274910800258
Financial ratios for CLAR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.27
Shares outstanding: 38441486
Market cap (USD): 164145145.21999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLAR — annual report dated 2024-12-31
Total revenue: 264315000
Gross profit: 92619000
Operating income: -23171000
Net income: -52287000
Capital expenditures: 6424000
Operating cash flow: -7300000
Depreciation & amortization: 13818000
Net tangible assets: 151023000
Owner earnings: -44893000
Return on net tangible assets (%): -29.725935784615586
Buffett classification: The Gruesome
Stock price: 4.3
Shares outstanding: 38441486
Book value: 233093000
P/B ratio: 0.709152097231577
Market cap (USD): 165298389.79999998
Debt to equity: 0.07141355596264153
Current ratio: 4.933263035213808
Quick ratio: 2.650109609567944
COGS to revenue (%): 64.95885591056127
SG&A to revenue (%): 43.807578079185824
Free cash flow (dilution-adjusted): -20118000
Buyback yield (%): 0.11191881555763347
Retained earnings: -406857000
Inventory turnover: 2.086778968861664
Receivables turnover: 5.927940252982865
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.97902401407441
FCF margin (%): -7.6113727938255495
Revenue growth (%): -7.588630165722677
Rule of 40 score: -15.200002959548225
Financial ratios for CLAR — quarterly report dated 2024-12-31
Total revenue: 71405000
Gross profit: 23865000
Operating income: -3954000
Net income: -65521000
Capital expenditures: 2144000
Operating cash flow: 16570000
Depreciation & amortization: 3451000
Owner earnings: -64214000
Buffett classification: The Gruesome
Stock price: 4.3
Shares outstanding: 38441486
Market cap (USD): 165298389.79999998
COGS to revenue (%): 66.57797073034101
SG&A to revenue (%): 38.959456620684826
Free cash flow (dilution-adjusted): 12785000
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): 17.904908619844548
Rule of 40 score: 17.904908619844548
Financial ratios for CLAR — quarterly report dated 2025-03-31
Total revenue: 60433000
Gross profit: 20794000
Operating income: -6447000
Net income: -5244000
Capital expenditures: 1181000
Operating cash flow: -2073000
Depreciation & amortization: 3107000
Net tangible assets: 148868000
Owner earnings: -3318000
Return on net tangible assets (%): -2.2288201628288147
Buffett classification: The Gruesome
Stock price: 3.6
Shares outstanding: 38441486
Book value: 229290000
P/B ratio: 0.6035559754023289
Market cap (USD): 138389349.6
Debt to equity: 0.07081425269309607
Current ratio: 4.455072318952811
Quick ratio: 2.2696909894831507
COGS to revenue (%): 65.59164694785962
SG&A to revenue (%): 45.0763655618619
Free cash flow (dilution-adjusted): -4723000
Buyback yield (%): 0.030349156290853756
Retained earnings: -413060000
Inventory turnover: 0.45310517471965983
Receivables turnover: 1.3716691633755504
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5501768154236846
FCF margin (%): -7.8152664934721106
Revenue growth (%): -15.365870737343323
Rule of 40 score: -23.181137230815434
Financial ratios for CLAR — quarterly report dated 2025-06-30
Total revenue: 55247000
Gross profit: 19680000
Operating income: -9067000
Net income: -8434000
Capital expenditures: 1809000
Operating cash flow: -9424000
Depreciation & amortization: 3090000
Net tangible assets: 148724000
Owner earnings: -7153000
Return on net tangible assets (%): -4.809580161910653
Buffett classification: The Gruesome
Stock price: 3.36
Shares outstanding: 38441486
Book value: 225120000
P/B ratio: 0.5737535223880597
Market cap (USD): 129163392.96
Debt to equity: 0.07057569296375267
Current ratio: 4.554626417439031
Quick ratio: 2.1850566975612282
COGS to revenue (%): 64.37815627997901
SG&A to revenue (%): 52.03359458432132
Free cash flow (dilution-adjusted): -12842000
Buyback yield (%): 0
Retained earnings: -422455000
Inventory turnover: 0.38859571492565037
Receivables turnover: 1.3872093607191283
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.657759274499363
FCF margin (%): -23.244701069741343
Revenue growth (%): -8.581404199692221
Rule of 40 score: -31.82610526943356
Financial ratios for CLAR — quarterly report dated 2025-09-30
Total revenue: 69347000
Gross profit: 24366000
Operating income: -2790000
Net income: -1617000
Capital expenditures: 1199000
Operating cash flow: -5737000
Depreciation & amortization: 3043000
Net tangible assets: 151212000
Owner earnings: 227000
Buffett classification: The Gruesome
Stock price: 3.41
Shares outstanding: 38441486
Book value: 225805000
P/B ratio: 0.580525086955559
Market cap (USD): 131085467.26
Debt to equity: 0.06640685547264233
Current ratio: 4.659888059701492
Quick ratio: 2.353224946695096
COGS to revenue (%): 64.86365668305767
SG&A to revenue (%): 39.15958873491283
Free cash flow (dilution-adjusted): -8496000
Buyback yield (%): 0
Retained earnings: -425032000
Inventory turnover: 0.5197351697363252
Receivables turnover: 1.2972967916939482
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1362248014660965
FCF margin (%): -12.251431208271446
Revenue growth (%): 25.521747787210163
Rule of 40 score: 13.270316578938717
Financial ratios for CLAR — quarterly report dated 2025-12-31
Total revenue: 65413000
Gross profit: 18136000
Operating income: -8575000
Net income: -31261000
Capital expenditures: 853000
Operating cash flow: 12488000
Depreciation & amortization: 3141000
Net tangible assets: 153032000
Owner earnings: -28973000
Return on net tangible assets (%): -18.932641539024516
Buffett classification: The Gruesome
Stock price: 3.29
Shares outstanding: 38441486
Book value: 196393000
P/B ratio: 0.6439765619955904
Market cap (USD): 126472488.94
Debt to equity: 0.06256332965024211
Current ratio: 4.233791894094693
Quick ratio: 2.1831608585047793
COGS to revenue (%): 72.27462431015242
SG&A to revenue (%): 40.83439071744149
Free cash flow (dilution-adjusted): 10258000
Buyback yield (%): 0
Retained earnings: -457253000
Inventory turnover: 0.5694103194103194
Receivables turnover: 1.4144574665917051
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.1119406921487105
FCF margin (%): 15.681898093651109
Revenue growth (%): -5.67292024168313
Rule of 40 score: 10.008977851967979
Financial ratios for CLAR — annual report dated 2025-12-31
Total revenue: 250440000
Gross profit: 82976000
Operating income: -26879000
Net income: -46556000
Capital expenditures: 5042000
Operating cash flow: -4746000
Depreciation & amortization: 12381000
Net tangible assets: 153032000
Owner earnings: -39217000
Return on net tangible assets (%): -25.626666318155678
Buffett classification: The Gruesome
Stock price: 3.29
Shares outstanding: 38441486
Book value: 196393000
P/B ratio: 0.6439765619955904
Market cap (USD): 126472488.94
Debt to equity: 0.06256332965024211
Current ratio: 4.233791894094693
Quick ratio: 2.1831608585047793
COGS to revenue (%): 66.86791247404568
SG&A to revenue (%): 43.86479795559814
Free cash flow (dilution-adjusted): -15803000
Buyback yield (%): 0.03320880323619256
Retained earnings: -457253000
Inventory turnover: 2.0169581346051935
Receivables turnover: 5.415387276737447
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.88919578592014
FCF margin (%): -6.310094234147899
Revenue growth (%): -5.249418307701038
Rule of 40 score: -11.559512541848937
Financial ratios for CNX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.75
Shares outstanding: 141477594
Market cap (USD): 1945316917.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNX — annual report dated 2022-12-31
Total revenue: 3924986000
Gross profit: 2797105000
Operating income: 2603345000
Net income: -142077000
Capital expenditures: 565754000
Operating cash flow: 1235014000
Depreciation & amortization: 461215000
Net tangible assets: 2550157000
Owner earnings: -246616000
Return on net tangible assets (%): -9.670620279457303
Capex to operating income (%): 21.731810420823976
Buffett classification: The Great
Stock price: 16.84
Shares outstanding: 141477594
Book value: 2950461000
P/B ratio: 0.8074950602499067
Market cap (USD): 2382482682.96
Debt to equity: 0.8094080891087867
Current ratio: 0.4370827633066322
Quick ratio: 0.416397268746896
Interest coverage ratio: 20.388169693552303
COGS to revenue (%): 28.735924153614818
SG&A to revenue (%): 3.100571568917698
Free cash flow (dilution-adjusted): 652885000
Buyback yield (%): 23.7200045163765
Retained earnings: 448993000
Inventory turnover: 41.53339961702754
Receivables turnover: 11.06745957895568
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.14266561469305
FCF margin (%): 16.634072070575538
Rule of 40 score: 16.634072070575538
Financial ratios for CNX — annual report dated 2023-12-31
Total revenue: 1506296000
Gross profit: 529573000
Operating income: 314187000
Net income: 1720716000
Capital expenditures: 679404000
Operating cash flow: 814588000
Depreciation & amortization: 433586000
Net tangible assets: 3967265000
Owner earnings: 1474898000
Return on net tangible assets (%): 37.17669477587204
Capex to operating income (%): 216.24191962111735
Buffett classification: The Gruesome
Stock price: 20
P/E ratio: 1.6444037714532787
Shares outstanding: 141477594
Book value: 4361017000
P/B ratio: 0.6488284452915455
Market cap (USD): 2829551880
Debt to equity: 0.5423179960087292
Current ratio: 0.5125018529814167
Quick ratio: 0.4883875780986102
Effective tax rate (%): 22.592260197712474
Interest coverage ratio: 2.1928488672371196
COGS to revenue (%): 64.84270023952796
SG&A to revenue (%): 8.321339232129676
Free cash flow (dilution-adjusted): 114949000
Buyback yield (%): 11.30447553412592
Retained earnings: 1981860000
Inventory turnover: 49.21510631865363
Receivables turnover: 11.241769969624826
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.026149784351161
FCF margin (%): 7.631235826159003
Revenue growth (%): -61.622894960644444
Rule of 40 score: -53.991659134485445
Financial ratios for CNX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.57
Shares outstanding: 141477594
Market cap (USD): 4607925236.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.67
Shares outstanding: 141477594
Market cap (USD): 5187983371.9800005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNX — annual report dated 2024-12-31
Total revenue: 1439191000
Gross profit: 413769000
Operating income: 169323000
Net income: -90494000
Capital expenditures: 540332000
Operating cash flow: 815779000
Depreciation & amortization: 485754000
Net tangible assets: 3710831000
Owner earnings: -145072000
Return on net tangible assets (%): -3.909420827841527
Capex to operating income (%): 319.113174229136
Buffett classification: The Gruesome
Stock price: 36.67
Shares outstanding: 141477594
Book value: 4098030000
P/B ratio: 1.2659700812292736
Market cap (USD): 5187983371.9800005
Debt to equity: 0.5593587650651655
Current ratio: 0.33016414004193917
Quick ratio: 0.3171833048572126
Interest coverage ratio: 1.1243675046814614
COGS to revenue (%): 71.24988969497447
SG&A to revenue (%): 10.978389942683076
Free cash flow (dilution-adjusted): 255356000
Buyback yield (%): 3.550570362173283
Retained earnings: 1753293000
Inventory turnover: 70.3693384573154
Receivables turnover: 7.290512953000415
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2914542261979274
FCF margin (%): 17.74302368483405
Revenue growth (%): -4.454967682314765
Rule of 40 score: 13.288056002519285
Financial ratios for CNX — quarterly report dated 2025-03-31
Total revenue: 610608000
Gross profit: 345572000
Operating income: 290490000
Net income: -197715000
Capital expenditures: 131465000
Operating cash flow: 215656000
Depreciation & amortization: 127062000
Net tangible assets: 3385213000
Owner earnings: -202118000
Return on net tangible assets (%): -5.970613961366685
Capex to operating income (%): 45.256291094357806
Buffett classification: The Good
Stock price: 31.48
Shares outstanding: 141477594
Book value: 3770774000
P/B ratio: 1.1811141848119247
Market cap (USD): 4453714659.12
Debt to equity: 0.7410163006321779
Current ratio: 0.26876737720111216
Quick ratio: 0.25133663488309066
Interest coverage ratio: 6.980918965682976
COGS to revenue (%): 43.405261640856324
SG&A to revenue (%): 6.878390063674239
Free cash flow (dilution-adjusted): 75375000
Buyback yield (%): 2.8097444398183726
Retained earnings: 1450844000
Inventory turnover: 9.605885977311441
Receivables turnover: 2.046787899103327
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8919769726370532
FCF margin (%): 12.344253596415376
Rule of 40 score: 12.344253596415376
Financial ratios for CNX — quarterly report dated 2025-06-30
Total revenue: 541301000
Gross profit: 246427000
Operating income: 190657000
Net income: 432521000
Capital expenditures: 113565000
Operating cash flow: 282491000
Depreciation & amortization: 152595000
Net tangible assets: 3708790000
Owner earnings: 471551000
Return on net tangible assets (%): 12.714416292106051
Capex to operating income (%): 59.56508284510929
Buffett classification: The Good
Stock price: 33.68
P/E ratio: 20.293201050739757
Shares outstanding: 141477594
Book value: 4092713000
P/B ratio: 1.1642559265504324
Market cap (USD): 4764965365.92
Debt to equity: 0.6678948658261648
Current ratio: 0.3291563794426405
Quick ratio: 0.2963279933003975
Effective tax rate (%): 26.14571042669485
Interest coverage ratio: 4.3290797211689105
COGS to revenue (%): 54.475051773412574
SG&A to revenue (%): 6.0964232469550215
Free cash flow (dilution-adjusted): 163842000
Buyback yield (%): 2.4284331808077773
Retained earnings: 1797896000
Inventory turnover: 7.499720229920138
Receivables turnover: 2.490824506023431
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.447400472183969
FCF margin (%): 30.268187200836504
Revenue growth (%): -11.35049000340644
Rule of 40 score: 18.917697197430066